Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Profit After Tax (2022 - 2025)

Historic Profit After Tax for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$73.9 million.

  • Praxis Precision Medicines' Profit After Tax fell 4242.73% to -$73.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.0 million, marking a year-over-year decrease of 8079.96%. This contributed to the annual value of -$182.8 million for FY2024, which is 4829.94% down from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Profit After Tax is -$73.9 million, which was down 4242.73% from -$71.1 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Profit After Tax ranged from a high of -$24.6 million in Q3 2023 and a low of -$73.9 million during Q3 2025
  • Its 4-year average for Profit After Tax is -$49.0 million, with a median of -$43.9 million in 2022.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 4549.38% in 2023, then tumbled by 11831.61% in 2024.
  • Quarter analysis of 4 years shows Praxis Precision Medicines' Profit After Tax stood at -$41.2 million in 2022, then skyrocketed by 34.72% to -$26.9 million in 2023, then tumbled by 118.32% to -$58.7 million in 2024, then decreased by 26.0% to -$73.9 million in 2025.
  • Its Profit After Tax stands at -$73.9 million for Q3 2025, versus -$71.1 million for Q2 2025 and -$69.3 million for Q1 2025.